EPB41L3 and non-small cell lung carcinoma: The high miR-223 levels in platelet-secreted EVs from non-small-cell lung carcinoma (NSCLC) patients reduce the protein level of the tumor suppressor EPB41L3, promoting lung cancer cell invasion (42).